Since the early 1900s, scientists have been using conventional 2D cell culture to study human biology and have made significant advancements in the field. However, it has become increasingly clear that the artificial nature of 2D cell culture, which includes the use of cancerous cell lines, static microenvironments, and limited cellular complexity, restricts its ability to accurately model human diseases and predict human reactions to drug candidates.
In a webinar led by Luke Dimasi, Senior Director of Product Management at Emulate, an overview of the Emulate Organ-on-a-Chip technology is provided. The webinar explores the advantages of Organ-Chips over 2D cell culture and offers data-driven examples demonstrating their enhanced physiological relevance.
Organ-Chips are an innovative cell culture technology that offers a more human-relevant platform for disease research and drug discovery and development. These advanced in vitro models replicate the microenvironment that cells experience within the human body, providing a more authentic representation of human responses compared to traditional 2D cell culture. By offering a more physiologically relevant platform for research, Organ-Chips have the potential to significantly improve our understanding of complex diseases such as cancer and neurological disorders.
